Ann: Cortical Invited to Austrade Korean Medtech Showcase-BPH.AX, page-2

CORTICAL DYNAMICS INVITED TO ATTEND AUSTRADE KOREAN MEDTECH INNOVATION SHOWCASE Cortical Dynamics Limited (“Cortical”) is pleased to advise that it has been invited by the Australian Trade and Investment Commission (“Austrade”) to attend and present at the Austrade Medtech Innovation Showcase 2016 to be held in Korea. The Showcase will bring together Australia’s key industry experts and innovative Medtech companies with senior executives from leading Korean pharma and medical device companies. Cortical Chairman, Mr David Breeze will be presenting Cortical and its next generation Brain Function Monitor. Organised by Austrade, with the support of the Department of Foreign Affairs and Trade (DFAT) and the Korean Health Innovation Development Institute (KHIDI) the showcase will provide a platform for Australian medtech organisations to meet with Korean businesses that are interested in partnering with Australian technology and solutions providers. .  Korea is Australia’s third largest export market, ahead of India and the USA. It is also Australia’s fourth largest two-way trading partner.  The Korean government has recently launched the “Creative Economy” industry policy which is aimed at revitalising the Korean manufacturing sector, creating new markets and enabling industry convergence across advanced manufacturing and materials, biotech and healthcare sector. The Korean biotech & healthcare industry enjoys strong government support. Opportunities for partnerships with Australian medtech and biotech companies are growing, building on the strong base of cooperation established by Australian and Korean biotech industries and the Korea Australia Free Trade Agreement The Korean Ministry of Science, ICT and Future Planning has designated brain research as one of their five main fields to receive the greater part of the investments. In particular, development of technologies to meet social issues such as “brain mapping” and early diagnosis services for dementia patients & development of technologies (i.e. customised brain disease treatment, neuro-rehabilitating brain stimulation, optimized learning capability technology) for four major fields in brain research; brain disease, cranial nerve, brain and cognitive science, brain engineering. (Source: Biotechnology in Korea, Ministry of Science, ICT and Future Planning)